Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease - Takeaways - MDSpire

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

  • By

  • David Marti-Aguado

  • Clara Alfaro-Cervello

  • Matías Fernández-Patón

  • Amadeo Ten-Esteve

  • Leonor Cerdá-Alberich

  • Ana Crespo

  • Irene Navarrete-Pérez

  • María Pilar Ballester

  • Alexandre Perez-Girbes

  • Cristina Montón

  • Judith Pérez-Rojas

  • Víctor Puglia

  • Antonio Ferrández

  • Victoria Aguilera

  • Desamparados Escudero-García

  • Salvador Benlloch

  • Ana Jimenez-Pastor

  • Ángel Alberich-Bayarri

  • Claude B. Sirlin

  • Luis Marti-Bonmati

  • August 8, 2025

  • 0 min

Share

  • 1

    Steatotic liver disease is assessed primarily through histological evaluation, which has inherent subjectivity and potential pitfalls.

  • 2

    MRI-proton density fat fraction (PDFF) is a non-invasive method that may be more sensitive than biopsy for detecting liver fat changes.

  • 3

    Discrepancies exist between histological and MRI-PDFF grading of steatosis, impacting clinical practice and treatment response assessments.

  • 4

    Digital image analysis (DIA) is proposed as a more accurate technique for quantifying lipid droplet size and distribution in liver biopsies.

  • 5

    The study aims to explore the relationship between lipid droplet size distribution and grading discrepancies in steatosis using a large patient cohort.

Original Source(s)

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

  • by David Marti-Aguado, Clara Alfaro-Cervello, Matías Fernández-Patón, Amadeo Ten-Esteve, Leonor Cerdá-Alberich, Ana Crespo, Irene Navarrete-Pérez, María Pilar Ballester, Alexandre Perez-Girbes, Cristina Montón, Judith Pérez-Rojas, Víctor Puglia, Antonio Ferrández, Victoria Aguilera, Desamparados Escudero-García, Salvador Benlloch, Ana Jimenez-Pastor, Ángel Alberich-Bayarri, Claude B. Sirlin, Luis Marti-Bonmati

  • August 8, 2025

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Prevalence and Risk Factors of Liver Fibrosis Among People With HIV and Metabolic Dysfunction–Associated Steatotic Liver Disease

Factors Related to Textbook Outcome in Laparoscopic Liver Resections: a Single Western Centre Analysis